LITERATURE REVIEW: POTENTIAL OF THE COMBINATION OF MINT LEAVES AND CARAWAY OIL AS A FUNCTIONAL DISPEPSIA THERAPY
Article Sidebar
Published:
Feb 23, 2021
Main Article Content
Abstract
Functional dyspepsia affects> 20% of the general population. The symptoms of functional dyspepsia are often associated with impaired quality of life of the patient. Until now, the treatment of functional dyspepsia is still controversial. Therefore, there needs to be a review of other alternative therapies, such as traditional medicine. The literature review shows that combination therapy of peppermint oil and caraway oil has synergistic activity because peppermint oil has spasmolytic properties and caraway oil plays a role in increasing smooth muscle tone so that it is effective in relieving pain and discomfort in patients with functional dyspepsia. Further research development with a larger scale and long term is needed to evaluate the effectiveness of this herbal therapy.
Article Details
How to Cite
Seipalla, F. (2021). LITERATURE REVIEW: POTENTIAL OF THE COMBINATION OF MINT LEAVES AND CARAWAY OIL AS A FUNCTIONAL DISPEPSIA THERAPY. JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia, 8(3), 120-127. https://doi.org/10.53366/jimki.v8i3.256
Section
Article Review
References
1. Leonardo H. Eusebi, Raguprakash Ratnakumaran, Franco Bazzoli, Alexander C. Ford. Prevalence of Dispepsia in Individuals with Gastroesophageal Reflux–Type Symptoms in the Community: A Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology. January 2018;Volume 16, Issue 1, Pages 39–48. e1
2. Max J Schmulson, Douglas A Drossman. What Is New in Rome IV. J Neurogastroenterol Motil. 2017 Apr; 23(2): 151–163.
3. Ford AC, Marwaha A, Sood R, Moayyedi P. Global prevalence of, and risk factors for, uninvestigated dispepsia: a meta-analysis. Gut. 2015; 64: 1049–57
4. Imran Aziz, Olafur S Palsson, Hans Törnblom, Ami D Sperber, William E Whitehead, Magnus Simrén. Epidemiology, clinical characteristics, and associations for symptom-based Rome IV functional dispepsia in adults in the USA, Canada, and the UK: a cross-sectional population-based study. Lancet Gastroenterol Hepatol. 2018.
5. Goshal UC, Singh R, Chang F, Hou X, Wong B. CY, Kachintorn U. Epidemiology of uninvestigated and functional dispepsia in Asia: fact and fiction. JNM. 2011;17(3).
6. Mudjaddid E. Dispepsia fungsional. Buku Ajar: Ilmu Penyakit Dalam. Edisi ke-5. Jakarta: Balai Penerbit FK UI; 2009;hlm.2109-10.
7. Harahap Y. Karakteristik penderita dispepsia rawat inap di RS Martha Friska Medan tahun 2007 (skripsi). Medan: Fakultas Kesehatan Masyarakat. 2009.
8. Yui Muya, Arina Widya Murni, Rahmatina B. Herman. Karakteristik Penderita Dispepsia Fungsional yang Mengalami Kekambuhan di Bagian Ilmu Penyakit Dalam RSUP Dr. M. Djamil Padang, Sumatera Barat Tahun 2011. Jurnal fk unand. 2011.
9. Brook RA, Kleinman NL, Choung RS, Melkonian AK, Smeeding JE, Talley NJ. Functional dispepsia impacts absenteeism and direct and indirect costs. Clin Gastroenterol Hepatol. 2010;8: 498–503.
10. Fang YJ, Liou JM, Chen CC, et al. Distinct aetiopathogenesis in subgroups of functional dispepsia according to the Rome III criteria. Gut. 2015;64: 1517–28.
11. Hsu YC, Liou JM, Liao SC, et al. Psychopathology and personality trait in subgroups of functional dispepsia based on Rome III criteria. Am J Gastroenterol. 2009;104: 2534–42.
12. Aro P, Talley NJ, Agréus L, et al. Functional dispepsia impairs quality of life in the adult population. Aliment Pharmacol Ther. 2011;33: 1215–24.
13. B. E. Lacy, K. T. Weiser, A. T. Kennedy, M. D. Crowell, and N. J. Talley, “Functional dispepsia: the economic impact to patients. Alimentary Pharmacology and Therapeutics. 2013;vol. 38, no. 2, pp. 170–177.
14. C. J. Black, L. A. Houghton, and A. C. Ford. Insights into the evaluation and management of dispepsia: recent developments and new guidelines. Therapeutic Advances in Gastroenterology. 2018;vol. 11.
15. M. Hawthorn, J. Ferrante, E. Luchowski et al. The actions of daun mint oil and menthol on calcium channel dependent processes in intestinal, neuronal and cardiac preparations. Alimentary Pharmacology and Therapeutics. 1988;vol. 2, no. 2, pp. 101–118.
16. A. Papathanasopoulos, A. Rotondo, P. Janssen et al., “Effect of acute daun mint oil administration on gastric sensorimotor function and nutrient tolerance in health. Neurogastroenterology and Motility. 2013;vol. 25, no. 4, pp. e263–e271.
17. B. May, P. Funk and B. Schneider, Daun mint oil and caraway oil in functional dispepsia — efficacy unaffected by H. pylori. Alimentary Pharmacology & Therapeutics. 2003;17, 7, (975-976).
18. G. H. Micklefield, I. Greving, and B. May. Effects of daun mint oil and caraway oil on gastroduodenal motility. Phytotherapy Research. 2000;vol. 14, no. 1, pp. 20–23.
19. G. Micklefield, O. Jung, I. Greving, and B. May. Effects of intraduodenal application of daun mint oil (WS 1340) and caraway oil (WS 1520) on gastroduodenal motility in healthy volunteers. Phytotherapy Research. 2003;vol. 17, no. 2, pp. 135–140.
20. B. Adam, T. Liebregts, J. Bes et al. A combination of daun mint oil and caraway oil attenuates the post-inflammatory visceral hyperalgesia in a rat model. Scandinavian Journal of Gastroenterology. 2006;vol. 41, no. 2, pp. 155–160.
21. Masuy I, Oudenhove LV, Tack J. Review Article: Treatment Options for Functional Dispepsia. Alimentary Pharmacology & Therapeutics. 2019; 49:1134–1172.
22. Shams R, Oldfield E C, Copare J, Johnson DA. Daun mint oil: Clinical Uses in the Treatment of Gastrointestinal Disease. JSM Gas¬troenterol Hepatol. 2015. 3(1): 1036.
23. Balakrishnan A. Therapeutic Uses of Daun mint – A Review. J. Pharm. Sci. & Res. 2015; 7(7), 474-476
24. Brun R & Kuo B. Functional Dispepsia. Ther Adv Gastroenterol. 2010; 3(3) 145_164
25. Kligler B & Chaudhary S. Daun mint Oil. Fam Physician. 2007; 75:1027-30
26. Chiarioni G, Pesce M, Fantin A, Sarnelli G. Complementary and Alternatif Treatment in Functional Dispepsia. United European Gastroenterology Journal, 2018; 6(1) 5–12
27. Rich G, Shah A, Koloski N, Funk P, Stracke B, Kohler S, Holtmann G. A randomized placebo‐controlled trial on the effects of Menthacarin, a proprietary daun mint‐ and caraway‐oil preparation, on symptoms and quality of life in patients with functional dispepsia. Neurogastroenterology&Motility. 2017;29. https://doi.org/10.1111/nmo.13132
28. May B, Kohler S and Schneider B. Efficacy and tolerability of a fixed combination of daun mint oil and caraway oil in patients suffering from functional dispepsia. Aliment Pharmacol Ther. 2000; 14: 1671–1677.
29. Mizuno S, Kato K, Ono Y, Yano K, Kurosaka H, Takahashi A, Abeta H, Kushiro T, Miyamoto S, Kurihara R, Hiki N, Kaminishi M, Iwasaki A, Arakawa Y. Oral daun mint oil is a useful antispasmodic for double-contrast barium meal examination. J Gastroenterol Hepatol. 2006; 21: 1297-1301.
30. Goerg KJ, Spilker T. Effect of daun mint oil and caraway oil on gastrointestinal motility in healthy volunteers: a pharmacodynamic study using simultaneous determination of gastric and gall-bladder emptying and orocaecal transit time. Aliment Pharmacol Ther. 2003; 17: 445-451.
31. Inamori M, Akiyama T, Akimoto K, Fujita K, Takahashi H, Yoneda M, Abe Y, Kubota K, Saito S, Ueno N, Nakajima A. Early effects of daun mint oil on gastric emptying: a crossover study using a continuous real-time 13C breath test (BreathID system). J Gastroenterol. 2007; 42: 539-542.
2. Max J Schmulson, Douglas A Drossman. What Is New in Rome IV. J Neurogastroenterol Motil. 2017 Apr; 23(2): 151–163.
3. Ford AC, Marwaha A, Sood R, Moayyedi P. Global prevalence of, and risk factors for, uninvestigated dispepsia: a meta-analysis. Gut. 2015; 64: 1049–57
4. Imran Aziz, Olafur S Palsson, Hans Törnblom, Ami D Sperber, William E Whitehead, Magnus Simrén. Epidemiology, clinical characteristics, and associations for symptom-based Rome IV functional dispepsia in adults in the USA, Canada, and the UK: a cross-sectional population-based study. Lancet Gastroenterol Hepatol. 2018.
5. Goshal UC, Singh R, Chang F, Hou X, Wong B. CY, Kachintorn U. Epidemiology of uninvestigated and functional dispepsia in Asia: fact and fiction. JNM. 2011;17(3).
6. Mudjaddid E. Dispepsia fungsional. Buku Ajar: Ilmu Penyakit Dalam. Edisi ke-5. Jakarta: Balai Penerbit FK UI; 2009;hlm.2109-10.
7. Harahap Y. Karakteristik penderita dispepsia rawat inap di RS Martha Friska Medan tahun 2007 (skripsi). Medan: Fakultas Kesehatan Masyarakat. 2009.
8. Yui Muya, Arina Widya Murni, Rahmatina B. Herman. Karakteristik Penderita Dispepsia Fungsional yang Mengalami Kekambuhan di Bagian Ilmu Penyakit Dalam RSUP Dr. M. Djamil Padang, Sumatera Barat Tahun 2011. Jurnal fk unand. 2011.
9. Brook RA, Kleinman NL, Choung RS, Melkonian AK, Smeeding JE, Talley NJ. Functional dispepsia impacts absenteeism and direct and indirect costs. Clin Gastroenterol Hepatol. 2010;8: 498–503.
10. Fang YJ, Liou JM, Chen CC, et al. Distinct aetiopathogenesis in subgroups of functional dispepsia according to the Rome III criteria. Gut. 2015;64: 1517–28.
11. Hsu YC, Liou JM, Liao SC, et al. Psychopathology and personality trait in subgroups of functional dispepsia based on Rome III criteria. Am J Gastroenterol. 2009;104: 2534–42.
12. Aro P, Talley NJ, Agréus L, et al. Functional dispepsia impairs quality of life in the adult population. Aliment Pharmacol Ther. 2011;33: 1215–24.
13. B. E. Lacy, K. T. Weiser, A. T. Kennedy, M. D. Crowell, and N. J. Talley, “Functional dispepsia: the economic impact to patients. Alimentary Pharmacology and Therapeutics. 2013;vol. 38, no. 2, pp. 170–177.
14. C. J. Black, L. A. Houghton, and A. C. Ford. Insights into the evaluation and management of dispepsia: recent developments and new guidelines. Therapeutic Advances in Gastroenterology. 2018;vol. 11.
15. M. Hawthorn, J. Ferrante, E. Luchowski et al. The actions of daun mint oil and menthol on calcium channel dependent processes in intestinal, neuronal and cardiac preparations. Alimentary Pharmacology and Therapeutics. 1988;vol. 2, no. 2, pp. 101–118.
16. A. Papathanasopoulos, A. Rotondo, P. Janssen et al., “Effect of acute daun mint oil administration on gastric sensorimotor function and nutrient tolerance in health. Neurogastroenterology and Motility. 2013;vol. 25, no. 4, pp. e263–e271.
17. B. May, P. Funk and B. Schneider, Daun mint oil and caraway oil in functional dispepsia — efficacy unaffected by H. pylori. Alimentary Pharmacology & Therapeutics. 2003;17, 7, (975-976).
18. G. H. Micklefield, I. Greving, and B. May. Effects of daun mint oil and caraway oil on gastroduodenal motility. Phytotherapy Research. 2000;vol. 14, no. 1, pp. 20–23.
19. G. Micklefield, O. Jung, I. Greving, and B. May. Effects of intraduodenal application of daun mint oil (WS 1340) and caraway oil (WS 1520) on gastroduodenal motility in healthy volunteers. Phytotherapy Research. 2003;vol. 17, no. 2, pp. 135–140.
20. B. Adam, T. Liebregts, J. Bes et al. A combination of daun mint oil and caraway oil attenuates the post-inflammatory visceral hyperalgesia in a rat model. Scandinavian Journal of Gastroenterology. 2006;vol. 41, no. 2, pp. 155–160.
21. Masuy I, Oudenhove LV, Tack J. Review Article: Treatment Options for Functional Dispepsia. Alimentary Pharmacology & Therapeutics. 2019; 49:1134–1172.
22. Shams R, Oldfield E C, Copare J, Johnson DA. Daun mint oil: Clinical Uses in the Treatment of Gastrointestinal Disease. JSM Gas¬troenterol Hepatol. 2015. 3(1): 1036.
23. Balakrishnan A. Therapeutic Uses of Daun mint – A Review. J. Pharm. Sci. & Res. 2015; 7(7), 474-476
24. Brun R & Kuo B. Functional Dispepsia. Ther Adv Gastroenterol. 2010; 3(3) 145_164
25. Kligler B & Chaudhary S. Daun mint Oil. Fam Physician. 2007; 75:1027-30
26. Chiarioni G, Pesce M, Fantin A, Sarnelli G. Complementary and Alternatif Treatment in Functional Dispepsia. United European Gastroenterology Journal, 2018; 6(1) 5–12
27. Rich G, Shah A, Koloski N, Funk P, Stracke B, Kohler S, Holtmann G. A randomized placebo‐controlled trial on the effects of Menthacarin, a proprietary daun mint‐ and caraway‐oil preparation, on symptoms and quality of life in patients with functional dispepsia. Neurogastroenterology&Motility. 2017;29. https://doi.org/10.1111/nmo.13132
28. May B, Kohler S and Schneider B. Efficacy and tolerability of a fixed combination of daun mint oil and caraway oil in patients suffering from functional dispepsia. Aliment Pharmacol Ther. 2000; 14: 1671–1677.
29. Mizuno S, Kato K, Ono Y, Yano K, Kurosaka H, Takahashi A, Abeta H, Kushiro T, Miyamoto S, Kurihara R, Hiki N, Kaminishi M, Iwasaki A, Arakawa Y. Oral daun mint oil is a useful antispasmodic for double-contrast barium meal examination. J Gastroenterol Hepatol. 2006; 21: 1297-1301.
30. Goerg KJ, Spilker T. Effect of daun mint oil and caraway oil on gastrointestinal motility in healthy volunteers: a pharmacodynamic study using simultaneous determination of gastric and gall-bladder emptying and orocaecal transit time. Aliment Pharmacol Ther. 2003; 17: 445-451.
31. Inamori M, Akiyama T, Akimoto K, Fujita K, Takahashi H, Yoneda M, Abe Y, Kubota K, Saito S, Ueno N, Nakajima A. Early effects of daun mint oil on gastric emptying: a crossover study using a continuous real-time 13C breath test (BreathID system). J Gastroenterol. 2007; 42: 539-542.